Centessa Pharmaceuticals PLC Sponsored ADR (CNTA)

Last Closing Price: 39.47 (2026-04-24)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Net Income of $-197.53M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$15.00M
Net Income
$-197.53M
--
$15.00M
$222.69M
$-207.69M
$11.98M
$-195.71M
$-195.71M
$-197.53M
$-197.53M
$-197.53M
$-197.53M
$-207.69M
$-205.62M
135.72M
135.72M
$-1.46
$-1.46
Balance Sheet Financials
$367.88M
$0.81M
$319.62M
$687.50M
$42.94M
$110.09M
$117.70M
$160.63M
$526.86M
$526.86M
$526.86M
149.23M
Cash Flow Statement Financials
$-193.82M
$-418.53M
$291.53M
$383.22M
$61.95M
$-321.27M
$30.96M
--
--
Fundamental Metrics & Ratios
8.57
--
--
0.17
0.21
100.00%
-1384.61%
-1384.61%
-1370.77%
-1304.75%
-1316.88%
$-194.19M
--
--
--
0.02
--
0.28
1311.98
-37.49%
-37.49%
-28.73%
-31.01%
$3.53
$-1.43
$-1.43